Notably, mutations in the SMAD2/4-binding sites abrogated the role of lnc-UTGF in promoting migration of hepatoma cells (Fig. 6h, Supplementary Fig. S14d), suggesting that lnc-UTGF may promote migration/invasion via SMAD2/4. The gene discussed is SMAD2; the disease is hepatocellular carcinoma.